Upcoming webinars:

Webinar 4: Surgical, medical, radiation treatment toxicity assessment, Quality of life assessment, Patients reported outcomes & Cervical Cancer

Chairs: Laura Farrelly, NCRI UK & Andreas du Bois, AGO Germany 
September 7, 2021
14.00-17.00 CEST

 

A. OPERATIONAL PART

14.00-14.00 What does the ENGOT Group do? – Andreas du Bois, AGO Germany

• Which study groups participate? Corresponding contact list
• Where do the studies come from, i.e. how is it decided whether a study will be conducted in the ENGOT group?
• What are the tasks of a lead group, how is the lead group determined?
• How are the tasks divided among the study groups?

14.40-15.00 Panel discussion

 

B. DISEASE PART 

15.00-15.20 Global incidence, evolution of screening methods and strategy, vaccination – Radoslaw Madry, PGOG Poland
15.20-15.40 Prognostic factors, work-up and staging - TBC
15.40-16.00 Surgical treatment in early stages, role of LN staging in locally advanced disease, and role of surgery in recurrent disease - Christian Marth, AGO Austria
16.00-16.20 Chemo (radiation) in adjuvant treatment, primary definitive treatment and palliation – Ketta Lorusso, MITO Italy
16.20-16.40 Systemic treatment in L1 and recurrent disease, current indications of targeted agents and Prospect of new treatment options – Mansoor Raza Mirza, NSGO-CTU, Denmark
16.40-17.00 Panel discussion

 

The registration link and detailed programme was sent out to the main representatives of the ENGOT Groups or you can ask for it at engot@esgo.org. 

All participants need to register. 

ENGOT Office will issue the certificates of the attendance at the end of the whole series in October. The attendees have to attend at least 4 webinars, live or watch them on demand on ESGO eAcademy. 
Please note that for receiving your certificate you should attend/ watch more than half of each webinar. 

 

 

Webinar 5: Designing a trial 

Chairs: Maren Keller, NOGGO Germany & Sandro Pignata, MITO Italy 
October 4, 2021
15.00-16.30 CEST